Clinical trial
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies
NCT02683538 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- July 31, 2014
- Enrollment
- 196 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cholangiocarcinoma, hepatocellular carcinoma, metastasis